FDA inspection
Mylan Laboratories Limited (FDF-2): FDA inspection ending Feb 28, 2020
FDA inspection 1122884 · No Action Indicated (NAI) · Chhatrapati Sambhajinagar
Key facts
| Inspection ID | 1122884 |
|---|---|
| Firm | Mylan Laboratories Limited (FDF-2) |
| FEI number | 3008316970 |
| Address | H-12 & H-13 Midc, Waluj |
| City | Chhatrapati Sambhajinagar |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Feb 28, 2020 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 607508 |
At a glance
- None Citations
- None Posted citations
- Yes Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data